A review on the research progress on... (2023 study) Skip to main content
Review Front Microbiol 2023

A review on the research progress on non-pharmacological therapy of Helicobacter pylori.

Luo Q, Liu N, Pu S, Zhuang Z, Gong H, Zhang D, Front Microbiol, 2023

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The authors wrote a review of treatments for Helicobacter pylori that do not rely on drugs, including hyperbaric oxygen therapy.

What They Found

This narrative review outlines how Helicobacter pylori colonizes the stomach and causes disease, and summarizes non-pharmacological treatment methods and their mechanisms. The abstract says the bacterium is the major cause of chronic gastritis, peptic ulcer and gastric cancer. It says standard treatment combines antibiotics with proton pump inhibitors, but growing antibiotic resistance limits how well this works. The methods covered are probiotics, an oxygen-rich environment or hyperbaric oxygen therapy, antibacterial photodynamic therapy, nanomaterials, antimicrobial peptide therapy, phage therapy and modified lysins. The abstract gives no figures, no hyperbaric pressure, and no session counts, and it reports no results for any single method.

What This Means for Canadian Patients

The abstract names hyperbaric oxygen therapy as one of several non-drug approaches that are expected to help address antibiotic resistance, and it says these approaches may become a new strategy. It does not say how well hyperbaric oxygen works for Helicobacter pylori, and it gives no treatment protocol. Patients with this infection should keep following the care plan from their own doctor.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This is a review that summarizes existing work, and the abstract reports no pooled data or patient outcomes, so it cannot show whether hyperbaric oxygen or any other listed method works in people.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Review
Category Wound Care
Source Pubmed
PubMed ID 37007498
Year Published 2023
Journal Front Microbiol

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: June 8, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology